PAIP 2023 Challenge Winner, MICCAI 2022 ACROBAT Challenge Winner
Spokane, wash., April 21, 2023 /PRNewswire/ — Gestalt Diagnostics honored with 1st Participate in both international challenges.Hundreds of groups participated in each challenge, and the Gestalt algorithm won the highest place.
of September 2022 Gestalt won 1st I participated in MICCAI’s breast cancer tissue auto-registration challenge.
upon April 18thth2023 Gestalt was named 1st Place winners in tumor cellularity prediction of PAIP in pancreatic and colon cancer challenges. The Gestalt algorithm had an ICC score of .9764 and an effectiveness of almost 98%.
International challenges allow companies such as Gestalt to collaborate with their colleagues on development by competing on items such as theory, applications and approaches, and ultimately, most importantly, applied science. Algorithms are scored for accuracy when reviewed systematically.
“These challenges are a great opportunity to compare and validate the techniques Gestalt uses to develop state-of-the-art image analysis algorithms to support the diagnostic workflows of physicians utilizing our digital pathology platform.” said. Brian NapolaGestalt VP, AI Solutions.
Gestalt Diagnostics Inc.
Gestalt Diagnostics transforms pathology through intelligent, configurable, vendor-neutral, AI-driven digital workflows that offer true interoperability to enable pathologists to diagnose disease faster and more efficiently* . Our PathFlow solution is a cloud-based digital pathology enterprise platform that can be easily customized based on your specific preferences. Our platform consists of professional, educational, and research modules to easily mix and match your facility’s digital needs in a single solution, freeing pathologists from tedious and repetitive manual tasks and providing expertise. It allows you to focus on your work and provides you with valuable expertise. it is the most important. For more information, visit www.gestaltdiagnostics.com and follow Gestalt on LinkedIn. @Gestalt 122 on Twitter.
Research Use Only (RUO) unless in accordance with LDT’s CAP guidelines.
SOURCE Gestalt diagnostics
